Skip to main content

1Provenance card

the boundary, as counts

Sources

4035 with DOI

15 strong · 20 moderate · 5 weak

Compilations

12026-05-03T10:41:16.016Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

30last ruled 2026-06-04

0 awaiting a ruling

Issued documents

62026-10-19T20:33:52.004Z

notice · info card · emergency

Searches

181 with no results

queries and counts on the build

Claims checked

8363 supported

63 supported · 20 not

Correspondence

0received

consent field ships in Phase 4

Edges

271

derivations recorded for this entity

Complete over 40 sources, 1 compilation, and 30 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/psilocin/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-10-19issueIssued notice
  4. 2026-09-24srcEffects of Psilocybin-Assisted Therapy on Major Depressive Disorder
  5. 2026-09-24srcAcute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects
  6. 2026-09-24srcPsilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen
  7. 2026-09-24srcIdentifizierung von Psilocin (Identification of Psilocin)
  8. 2026-09-24srcElucidating the Phase I metabolism of psilocin in vitro
  9. 2026-09-24srcPsilocybin with psychological support for treatment-resistant depression: six-month follow-up
  10. 2026-09-24srcClinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis
  11. 2026-09-24srcRecent advances in the neuropsychopharmacology of serotonergic hallucinogens
  12. 2026-09-24srcSerotonin 5-HT2A, 5-HT2C and 5-HT1A receptor involvement in the acute effects of psilocybin in mice
  13. 2026-09-24srcPsilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
  14. 2026-09-24srcModulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
  15. 2026-09-24srcReceptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
  16. 2026-09-24srcPrevalence and associations of challenging, difficult or distressing experiences using classic psychedelics
  17. 2026-09-24srcMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens
  18. 2026-09-24srcThe abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
  19. 2026-09-24srcSafety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review
  20. 2026-09-24srcPsilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
  21. 2026-09-24srcSynthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs
  22. 2026-09-24srcThe Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
  23. 2026-09-24srcPsychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
  24. 2026-09-24srcPsilocybin for treatment resistant depression in patients taking a concomitant SSRI medication
  25. 2026-09-24srcPsilocybin desynchronizes the human brain
  26. 2026-09-24srcPsychedelics promote plasticity by directly binding to BDNF receptor TrkB
  27. 2026-09-24srcDevelopment of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans
  28. 2026-09-24srcSingle-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
  29. 2026-09-24srcREBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
  30. 2026-09-24srcPsychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
  31. 2026-09-24srcBroadband Cortical Desynchronization Underlies the Human Psychedelic State
  32. 2026-09-24srcActivation of serotonin 2A receptors underlies the psilocybin-induced effects on alpha oscillations, N170 visual-evoked potentials, and visual hallucinations
  33. 2026-09-24srcThe entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
  34. 2026-09-24srcUnderlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats
  35. 2026-09-24srcThe 'Endless Trip' among NPS Users: Psychopathology and Psychopharmacology in HPPD. A Systematic Review
  36. 2026-09-24srcTrajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis
  37. 2026-09-24srcPharmacokinetics of Psilocybin: A Systematic Review
  38. 2026-09-24srcResearch on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice
  39. 2026-09-24srcPsilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
  40. 2026-09-24srcLysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain
  41. 2026-09-24srcPsilocin - Wikipedia
  42. 2026-09-24srcOregon Psilocybin Services Act (Measure 109)
  43. 2026-09-24srcFrom prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia
  44. 2026-09-04issueIssued emergency
  45. 2026-09-04issueIssued info_card
  46. 2026-09-04issueIssued notice
  47. 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  48. 2026-06-04publicationPublication — backfill
  49. 2026-05-03revisionRevision 1
  50. 2026-05-03absenceSearched PubMed for "psilocybin psilocin LD50 lethal dose animal" — no results
  51. 2026-05-03genGeneration — pipeline-v5pipeline-v5
  52. 2026-05-03rungeneration run

The same entries, as forms: six forms.